Kazia Therapeutics Files Form 6-K
Ticker: KZIA · Form: 6-K · Filed: Jul 25, 2025 · CIK: 1075880
| Field | Detail |
|---|---|
| Company | Kazia Therapeutics LTD (KZIA) |
| Form Type | 6-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, regulatory-filing
Related Tickers: KZA
TL;DR
Kazia Therapeutics (KZA) filed a 6-K on 7/25/25, standard reporting.
AI Summary
Kazia Therapeutics Limited filed a Form 6-K on July 25, 2025, reporting information for the month of July 2025. The company, previously known as Novogen Ltd, is based in Sydney, NSW, Australia, and operates in the pharmaceutical preparations industry. This filing is made under the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Kazia Therapeutics' ongoing operations and compliance as a foreign private issuer.
Risk Assessment
Risk Level: low — Form 6-K filings are typically routine disclosures and do not inherently represent significant new risks.
Key Players & Entities
- Kazia Therapeutics Limited (company) — Registrant
- Novogen Ltd (company) — Former company name
- July 25, 2025 (date) — Filing date
- Sydney NSW (location) — Company address
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the company makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
When was Kazia Therapeutics Limited previously known as?
Kazia Therapeutics Limited was previously known as Novogen Ltd, with a date of name change on December 28, 1998.
Where is Kazia Therapeutics Limited's principal executive office located?
The company's principal executive office is located at Three International Towers Level 24, 300 Barangaroo Avenue, Sydney NSW 2000.
Does Kazia Therapeutics Limited file annual reports under Form 20-F or Form 40-F?
Kazia Therapeutics Limited indicates that it files annual reports under cover of Form 20-F.
What is the SIC code for Kazia Therapeutics Limited?
The Standard Industrial Classification (SIC) code for Kazia Therapeutics Limited is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 25, 2025 regarding KAZIA THERAPEUTICS LTD (KZIA).